Mal G.S., Kuznetsov A.A. Coronary heart disease and chronic kidney disease: the possibilities of PCSK9 inhibitors in the achievement of atherogenic lipoproteins target values. Innovative Medicine of Kuban. 2022;(2):14-21. (In Russ.) https://doi.org/10.35401/2541-9897-2022-25-2-14-21
Email this article (Login required)
Email the author (Login required) 
Founder: Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 1
Registration number and date of registration: El No. FS77-83025 dated March 31, 2022.
Editorial office:
ulitsa 1 Maya 167, Krasnodar, 350086, Russian Federation
email: imk-journal@mail.ru, kkb1research@miackuban.ru
Phone: +7 (861) 252-83-34
